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Abstract
Objective—This study evaluated the efficacy of an Integrated Brain, Body, and Social (IBBS) 
intervention for children with ADHD. Treatment consisted of computerized cognitive remediation 
training, physical exercises, and a behavior management strategy.
Method—Ninety-two children aged 5 to 9 years with ADHD were randomly assigned to 15 
weeks of IBBS or to treatment-as-usual. Primary outcome measures included blinded clinician 
ratings of ADHD symptoms and global clinical functioning. Secondary outcome measures 
consisted of parent and teacher ratings of ADHD and neurocognitive tests.
Results—No significant treatment effects were found on any of our primary outcome measures. 
In terms of secondary outcome measures, the IBBS group showed significant improvement on a 
verbal working memory task; however, this result did not survive correction for multiple group 
comparisons.
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Conclusion—These results suggest that expanding cognitive training to multiple domains by 
means of two training modalities does not lead to generalized improvement of ADHD 
symptomatology.
Keywords
ADHD; computerized cognitive remediation training (CCRT); physical exercise; Good Behavior 
Game (GBG); randomized controlled trial
ADHD is a neurodevelopmental disorder that affects approximately 5% of school-age 
children (DuPaul, Reid, Anastopoulos, & Power, 2014; Polanczyk, Willcutt, Salum, Kieling, 
& Rohde, 2014) and often involves delays or inadequacies in the development of higher 
order cognitive processes including the ability to sustain, direct, and shift attention as well as 
monitor and self-regulate behavior (Barkley, 1997; Willcutt, Doyle, Nigg, Faraone, & 
Pennington, 2005). ADHD is a major public health problem as it is associated with impaired 
child and family functioning and high societal costs and often leads to academic 
underachievement, behavior problems, parent–child conflicts, and peer relationship 
difficulties (Barkley, Anastopoulos, Guevremont, & Fletcher, 1992; Bernfort, Nordfeldt, & 
Persson, 2008; Efron et al., 2014; Loe & Feldman, 2007; Marton, Wiener, Rogers, & Moore, 
2015). ADHD is considered a chronic disorder and, when it is not diagnosed and treated 
early on, it may result in various negative developmental outcomes (e.g., occupational 
problems, other psychiatric disorders, substance abuse, criminal activity) across the life span 
as well as an increased rate of mortality (Cherkasova, Sulla, Dalena, Pondé, & Hechtman, 
2013; Dalsgaard, Østergaard, Leckman, Mortensen, & Pedersen, 2015; Knecht, De Alvaro, 
Martinez-Raga, & Balanza-Martinez, 2015; Kooij et al., 2012; Kuriyan et al., 2013).
Neurobiology of ADHD
Neuroimaging studies have shown that there are various structural and functional brain 
abnormalities in children with ADHD (Cortese et al., 2012; Ellison-Wright, Ellison-Wright, 
& Bullmore, 2008). Specifically, children with ADHD have delayed cortical development, 
cortical thinning, and reductions in the volume of several brain regions including the 
prefrontal cortex and the temporal and parietal lobes (Fair et al., 2012; Shaw et al., 2007; 
Shaw et al., 2012; Shaw et al., 2009), which correspond to brain networks that support the 
regulation of attention, emotions, and behavior (Purper-Ouakil, Ramoz, Lepagnol-Bestel, 
Gorwood, & Simonneau, 2011). Moreover, the brain activity of children with ADHD when 
performing higher order cognitive tasks is most similar to their younger and typically 
developing peers (Fernández et al., 2009; Hart, Radua, Mataix-Cols, & Rubia, 2012). In fact, 
these higher order cognitive processes, particularly response inhibition, sustained attention, 
and working memory have been found to be impaired in children with ADHD (Crippa et al., 
2015; Pennington & Ozonoff, 1996; Willcutt et al., 2005). These underdeveloped brain 
regions, functional network abnormalities, and associated cognitive impairments may 
provide important neurocognitive targets for interventions.
Past research has shown that environmentally initiated training (i.e., sustained practice with 
a musical instrument or athletic activities) may lead to changes in regional brain volume and 
inter-regional connectivity patterns (Schlaug, 2001; Wang et al., 2013). Computerized 
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cognitive remediation training (CCRT) is a treatment approach based on a similar premise in 
that such training may result in enhancements in cortical activation and strengthening of 
cortical connections. In fact, CCRTs have been successful in adults by enhancing recovery 
from stroke, reducing cognitive impairments in schizophrenia, and addressing other 
neurological illnesses (Hildebrandt et al., 2007; Raskin & Sohlberg, 2009; Westerberg et al., 
2007; Wexler, Anderson, Fulbright, & Gore, 2000). Given the short- and long-term negative 
outcomes associated with ADHD, it is imperative to develop and evaluate the potential 
benefit of such interventions for ADHD in children as young as developmentally possible 
with the goal of improving their neural and behavioral development to prevent later 
maladaptive outcomes.
Current ADHD Treatments
Both psychopharmacological (Biederman, Spencer, & Wilens, 2004; Swanson, Baler, & 
Volkow, 2011) and non-pharmacological (Evans, Owens, & Bunford, 2014; Faraone & 
Antshel, 2014) interventions have shown to be efficacious in the treatment of ADHD. 
Although pharmacological treatment with psychostimulants are relatively safe and lead to 
symptom relief for most children (Biederman et al., 2004; Swanson et al., 2011), not all 
difficulties (e.g., cognitive deficits) associated with ADHD remit and the long-term benefits 
are limited (Molina et al., 2009; van de Loo-Neus, Rommelse, & Buitelaar, 2011). 
Alternatively, psychosocial and behavioral treatments, which primarily involve the 
systematic use of reinforcements (i.e., contingency management), have shown short-term 
behavioral gains equivalent to low-dose medication, yet these gains disappear once 
contingencies are removed (Carlson, Pelham, Milich, & Dixon, 1992; Pelham et al., 1993; 
Sagvolden, Johansen, Aase, & Russell, 2005). In outpatient behavior therapy, improvements 
over baseline are usually seen, but the resulting treatment effects are not as large as those in 
medication trials (Daly, Creed, Xanthopoulos, & Brown, 2007; Hinshaw, Klein, & Abikoff, 
1998; Pelham, Wheeler, & Chronis, 1998; Van der Oord, Prins, Oosterlaan, & Emmelkamp, 
2008). When combining both treatment modalities (i.e., medication plus behavior therapy), 
improvements in multiple areas of functioning (i.e., academics, comorbid psychiatric 
conditions, social skills, parent–child relationships) have been found and medication dosages 
may be lowered while maintaining these beneficial effects (Jensen, 1999; Van der Oord et 
al., 2008). Despite these advantages, neither treatment option alone or in its combined form 
completely addresses the neurocognitive pathology of ADHD, so it is possible that the long-
term course of the disorder may remain unaltered.
With this in mind, several CCRT interventions have been developed to target working 
memory as it is considered a fundamental higher order cognitive function underlying other 
cognitive functions and is essential for goal-directed behavior (Klingberg et al., 2005; 
Molfese & Molfese, 2002). It has been suggested that training working memory may 
improve working memory capacity, which in turn may positively affect other cognitive 
functions and ADHD symptoms (e.g., Chacko et al., 2014; Klingberg et al., 2005; van 
Dongen-Boomsma, Vollebregt, Buitelaar, & Slaats-Willemse, 2014). Indeed, several 
randomized controlled trials have shown improvements in working memory following 
treatment with CCRTs in children and adolescents with ADHD (Beck, Hanson, 
Puffenberger, Benninger, & Benninger, 2010; Chacko et al., 2014; Cortese et al., 2015; Gray 
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et al., 2012; Green et al., 2012; Holmes et al., 2010; Johnstone et al., 2012; Klingberg et al., 
2005; Sonuga-Barke et al., 2013). However, treatment effects have been less consistent for 
other non-trained neurocognitive outcome measures (e.g., sustained attention, response 
inhibition, processing speed) and for parent ratings of ADHD symptoms (Beck et al., 2010; 
Chacko et al., 2014; Gray et al., 2012; Green et al., 2012; Holmes et al., 2010; Johnstone et 
al., 2012; Klingberg et al., 2005; Shalev, Tsal, & Mevorach, 2007; van Dongen-Boomsma et 
al., 2014). Moreover, improvements in ADHD symptomatology and neurocognitive 
functioning as assessed by teacher and clinician ratings (i.e., blinded raters) have not 
typically been found (Beck et al., 2010; Chacko et al., 2014; Klingberg et al., 2005; van 
Dongen-Boomsma et al., 2014). It is possible that prior research has failed to find robust 
treatment effects for CCRTs because most have been designed to train only one higher order 
cognitive function (i.e., working memory), which may have limited transfer effects. In fact, 
Rapport, Orban, Kofler, and Friedman (2013) found in their meta-analysis that CCRTs 
showed evidence of near-transfer effects (e.g., trained cognitive domains), but not far-
transfer effects (e.g., non-trained cognitive domains, ADHD symptomatology). Considering 
ADHD impairs functioning across multiple domains, it stands to reason that interventions 
must target the core cognitive deficits associated with ADHD in addition to other areas of 
impairment (e.g., behavioral, motor, social) if treatment effects are expected to generalize.
In an effort to promote transfer effects, a new neuroscience-inspired intervention was 
designed to target eight cognitive functions (i.e., sustained attention, response inhibition, 
speed of processing, cognitive flexibility, multiple simultaneous attention, working memory, 
category formation, pattern recognition), which have been implicated in ADHD and form 
the groundwork of learning (Barkley, 1997; Crippa et al., 2015; Huang-Pollock, Maddox, & 
Tam, 2014; Pennington & Ozonoff, 1996; Willcutt et al., 2005). Considering a separate 
literature suggests that physical exercise can also improve these cognitive functions 
(Grassmann, Alves, Santos-Galduróz, & Galduróz, 2014; Kamp, Sperlich, & Holmberg, 
2014) and ADHD symptomatology (Abramovitch, Goldzweig, & Schweiger, 2013; Smith et 
al., 2013; Verret, Guay, Berthiaume, Gardiner, & Béliveau, 2012), sport activities designed 
to train the same cognitive abilities in the context of whole body activity and social 
activation also comprised this intervention. All in all, the training of both the mind and body 
was anticipated to maximize neurocognitive benefits so treatment effects would generalize to 
ADHD symptomatology.
Integrated Brain, Body, and Social (IBBS) Intervention
The purpose of this study was to evaluate the efficacy of a new IBBS intervention for 
children (aged 5–9 years) with ADHD. This multi-site randomized wait-list controlled study 
funded by the National Institutes of Health (NIH) Transformative Research Program was 
conducted in the United States and China (Title: Integrated Brain, Body, and Social (IBBS) 
intervention for Attention-Deficit/Hyperactivity Disorder; http://clinicaltrials.gov/ct2/show/
NCT01542528). This treatment is innovative in that it integrates two modalities of training 
(i.e., computerized cognitive training and physical exercises) and targets several higher order 
cognitive functions known to be implicated in ADHD with the goal of enhancing the activity 
of supporting brain networks to ameliorate symptoms of ADHD. Furthermore, the brain 
component of treatment builds upon past CCRTs as the difficulty level adjusts to the 
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performance of each child by means of graduation and plateau criteria and online corrective 
messages help children adopt new strategies to achieve success. Finally, behavioral 
techniques (i.e., Good Behavior Game [GBG]) are employed to assure children’s 
engagement in the brain and body components of treatment. In fact, previous studies have 
used reward systems to maximize compliance of children participating in clinical trials of 
CCRTs (e.g., Chacko et al., 2014).
Given the integrative nature of IBBS (i.e., comprised of multiple modalities of training) and 
the enhancements made to the brain component of treatment over and above existing CCRTs 
(i.e., difficulty of training matches performance level, online corrective messaging), it was 
hypothesized that children receiving IBBS would show significantly greater improvement 
than children receiving treatment-asusual (TAU) in ADHD symptomatology and global 
clinical functioning as rated by blinded clinicians. These treatment effects would also be 
observed on parent and teacher ratings of ADHD. Finally, children in the IBBS condition 
following treatment would outperform children in the TAU condition on neurocognitive tests 
that were specifically trained by IBBS.
Method
Participants
Children were eligible to participate in the study if the following criteria were met: (a) age 
between 5 and 9 years; (b) a diagnosis of ADHD (i.e., Combined, Predominantly Inattentive, 
and Predominantly Hyperactive-Impulsive types) according to the Diagnostic and Statistical 
Manual of Mental Disorders (4th ed., text rev.; DSM-IV-TR; American Psychiatric 
Association, 2000) or children at subthreshold for ADHD, defined as one symptom below 
diagnostic criteria; (c) an intellectual quotient of at least 80; and (d) on a stable dose of 
medication for at least 4 weeks (if on medication for ADHD). Children were excluded if 
they had a severe or impairing comorbid psychiatric diagnosis such as major depression, 
bipolar disorder, psychotic disorder, or acute behavior problems (e.g., temper tantrums, 
aggression, self-injury) that required immediate therapeutic attention or a documented 
physical disability or injury that would prevent them from participating in the IBBS 
treatment. A comorbid diagnosis of an autism spectrum disorder was not deemed 
exclusionary for study participants if their level of functioning did not interfere with their 
ability to participate in all aspects of the program.
A total of 112 children in the United States and China were assessed for eligibility. Of this 
potential participant pool, 92 children (72 from United States and 20 from China; M age = 
7.4 ± 1.1; 70% male) were enrolled into the study. Year of implementation determined to 
which cohort study participants belonged. Cohort 1 comprised of students from four 
elementary schools in a northeastern town in the United States as well as children living in a 
predominantly urban district of Beijing, China. Cohort 2 consisted of children enrolled in the 
remaining three elementary schools from the same U.S. school district as Cohort 1. See 
Table 1 for demographic and clinical characteristics of the sample disaggregated by 
treatment group. Of note, nine children in each group (i.e., IBBS, TAU) were determined to 
be subthreshold for ADHD. With regard to medication status, 12 children (six in each group) 
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were receiving one or more ADHD medications at baseline and were required to remain on 
the same type and dose of medication throughout the duration of the study.
IBBS Intervention
IBBS is comprised of three components including CCRT (i.e., brain component), physical 
exercise (i.e., body component), and a classroom-based behavior management strategy (i.e., 
social component). Each component is described in its respective section below.
Brain component—Three computer games were developed for the purpose of the IBBS 
intervention. At the most basic level, the first computer exercise resembled the continuous 
performance task and required children to click on presented stimuli when it changed from a 
default color to a target color. The cognitive capabilities required by this exercise included 
sustained attention, response inhibition, working memory, directed attention, attentional 
switching, and divided attention. The second exercise was most similar to inhibitory control 
paradigms such as the Go/No-Go task and instructed children to identify and click on 
members of a target category before they moved off the screen. Some categories were 
considered “natural” or “basic” (e.g., animals, furniture), whereas some fell on different 
ends of a continuum within the same category (e.g., small animals vs. large animals), and 
still others were regarded as “functional” or “temporary” categories (e.g., modes of 
transportation, household items). This computer exercise required the use of sustained 
attention, response inhibition, directed attention, visual searching, and category formation. 
The third exercise resembled the Wisconsin Card Sorting Task and had children determine 
the relationship among stimuli in the first row to make a selection from stimuli in the second 
row that completed the sequence in the first row. The cognitive abilities that were employed 
by this task included sustained attention, response inhibition, working memory, speed of 
processing, and category formation.
In all the games, several parameters of the program (e.g., number of targets on the screen, 
rate at which targets moved, complexity of rules to identify targets) were adjusted to 
increase the level of difficulty and were based on the performance of that child. This novel 
approach was performed by way of graduation and plateau criteria, such that children were 
moved through exercises quickly in areas of their strength and continued to work in areas of 
their weaknesses, but moved on once their maximum gain was reached. All responses made 
were recorded so progress was easily tracked and online corrective strategy messages were 
used to facilitate growth. In addition, program teachers were instructed to provide 
encouragement to support children’s efforts during these exercises and children were 
awarded points within the game framework based on individual performance, which could 
then be exchanged for virtual prizes. Each computerized cognitive training session lasted 30 
minutes and all three computer games were played within this time frame.
Body component—The body component of IBBS was intended to target the same 
cognitive functions as the brain component with the intent to increase the likelihood of 
activating and engaging attentional networks that support these functions. The decision to 
include physical exercise as part of the IBBS program was based on emerging evidence in 
the extant literature that physical exercise improves neurocognitive functioning in children 
Smith et al. Page 6
J Atten Disord. Author manuscript; available in PMC 2017 November 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
with ADHD (Grassmann et al., 2014; Halperin, Berwid, & O’Neill, 2014; Kamp et al., 
2014). In fact, two recent studies found that children with ADHD who were randomized to 
an exercise condition showed better accuracy and quicker performance on neurocognitive 
tasks (i.e., selective attention, sustained attention, cognitive flexibility, working memory) 
than children in the control condition (Chang, Liu, Yu, & Lee, 2012; Verret et al., 2012). 
One study also found transfer effects as parent and teacher ratings of inattention and social 
problems improved for children in the exercise condition (Verret et al., 2012).
The exercises designed for the IBBS program progressed gradually from single to multiple 
tasks and from simple to more complicated movements with different requirements for 
reaction time, speed of processing, and hand-eye-body coordination. These physical 
activities were designed to target specific cognitive functions thereby enhancing children’s 
abilities in these areas. Each IBBS exercise drew on several cognitive functions, with some 
depending more heavily on a particular cognitive ability than others (e.g., patterns through 
an agility ladder, ball skill acquisition, hula-hoop, juggling). See Supplementary Appendix 
S1 for further details concerning the body component of treatment. Study participants were 
closely monitored by instructors and provided feedback and support for developing these 
skills. Children participated in the body component of IBBS for 45 minutes each session.
Social component—The social component of IBBS was deemed important, as it would 
help limit behaviors that could potentially interfere with its successful implementation and 
would also facilitate participation among all children in the program. The GBG was selected 
for this purpose because it is the most thoroughly studied classroom-based strategy and has 
the most documented impact on the prevention of emotional and behavioral disorders and 
related sequelae according to the Institute of Medicine Report on Prevention (O’Connell, 
Boat, & Warner, 2009). In fact, two large-scale randomized controlled trials revealed that 
children who participated in the GBG for the entire academic year showed slower growth 
rates of hyperactive and oppositional symptoms (Leflot, Van Lier, Onghena, & Colpin, 
2010) and significant decreases in disruptive behavior, as rated by their teachers across the 
study period (Huizink, Van Lier, & Crijnen, 2008).
The version of the GBG that was used in the IBBS program was the response cost design. 
The majority of published studies employ this version and past research has found no 
differential benefits of allocating attention to rules violated (i.e., response cost) versus rules 
followed (i.e., reinforcement; Tanol, Johnson, McComas, & Cote, 2010). The GBG was 
played 3 to 5 times for 15 to 30 minutes (length of games gradually increased as disruptive 
behaviors decreased) each session during the brain and body components of IBBS.
During the first week of the IBBS program, behavioral observations were made to get a 
baseline assessment of how often program rule violations occurred and the frequency with 
which each child violated the rules or displayed disruptive and/or off-task behaviors. Based 
on this information, students were divided into two comparable teams and a maximum 
number of rule violations were agreed upon by teachers implementing IBBS. The same four 
rules used in the GBG manuals were employed, with one additional rule, “we will try our 
best,” inspired by the brain component of the IBBS protocol. This was included to promote 
positive engagement and to minimize avoidance behaviors when completing cognitively 
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taxing activities. To win the GBG, teams had to receive fewer rule violations than the 
maximum number permitted by their teachers. Winning teams were rewarded with 
immediate behavior rewards (e.g., follow the leader, “Simon says,” red light green light) 
lasting at most 5 minutes and more long-term tangible rewards (e.g., trip to the prize box) 
were given to the team that won the most games each week.
Treatment-As-Usual
Treatement-As-Usual (TAU) consisted of whatever the child was receiving at the time of 
study entry, which included (but was not limited to) psychosocial and/or 
psychopharmacological interventions for ADHD. As mentioned previously, six children in 
the TAU group were receiving one or more ADHD medication(s) at study entry. With regard 
to psychosocial services offered within the school, 12 had a one-to-one school aide, six had 
a behavior support plan, 10 received school counseling/psychological services, and 16 
received some other type of service (i.e., speech therapy, occupational therapy, tutoring). 
Outside of school, eight were receiving psychotherapy and 12 received some other type of 
service. Families were instructed to not make any changes to their children’s treatment 
regimens throughout the duration of the study.
IBBS Training and Treatment Integrity
In the United States, the IBBS intervention was delivered by classroom teachers and mental 
health professionals (e.g., school counselors, social workers) who were employed by the 
school district in which the IBBS program was taking place. Graduate and advanced 
undergraduate students (i.e., juniors and seniors) assisted program teachers in implementing 
the IBBS intervention. Prior to treatment delivery, teachers and assistants received 6 hours of 
training by the U.S. research team, which included the developers of the IBBS program. 
This training was supplemented by the research team modeling all elements of the treatment 
once the program began. The modeling phase of training ended once teachers and assistants 
were able to implement the program with full integrity and with limited feedback from the 
research team. Moreover, the research team held weekly meetings with program teachers to 
discuss implementation difficulties, behavior problems that interfered with treatment, and to 
plan upcoming sessions. In China, treatment was implemented by a research team consisting 
of seven highly trained graduate students enrolled in leading physical education programs 
because the IBBS program could not be implemented within the schools or by school 
personnel to respect the privacy of participating families. This research team was supervised 
and trained by the co-developer of IBBS and trainings were augmented with biweekly (then 
monthly) consultations with the U.S. research team during the first year of implementation.
In both the United States and China, a multi-faceted approach was taken by the research 
team to ensure treatment integrity. For the brain component of treatment, each participant 
received a uniform training package, as the length and order of the computer games across 
all 15 weeks were pre-determined prior to the start of the program. Compliance with the 
computer exercises was defined as the number of hours played, which is discussed further in 
the results section. The body component of treatment was also standardized so that the 
description, length, and order of the physical exercises were detailed in the IBBS manual. 
On a weekly basis, the research team observed its implementation and, if deviations from the 
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manual occurred, feedback was immediately provided so corrective actions could be taken. 
As the social component of treatment was less structured and required more flexibility on 
behalf of program teachers, the research team also completed integrity ratings on a weekly 
basis where all components of the GBG were rated as either present or absent to obtain an 
overall score. This score was rated on a 5-point Likert-type scale where 1 indicated not 
implemented and 5 indicated full integrity (scale adapted from Tanol et al., 2010). Overall, 
the GBG was implemented with adequate integrity (M = 4.05, SD = .71) and there were no 
significant differences in GBG integrity across implementation site or cohort. Following 
each assessment, feedback was provided to program teachers and further training was 
offered if necessary (i.e., if teachers’ received a score of 1 [not implemented], 2 [minimal 
integrity], or 3 [half/partial integrity]).
Procedure—All procedures were approved by the human investigation committee or by 
the scientific research ethics committee at the universities conducting this research. 
Informed consent was obtained from parents or guardians, and all participants gave informed 
assent prior to engaging in any study procedures. Families whose children were randomized 
to the IBBS and TAU groups were compensated US$40 for their time following each 
assessment visit.
Recruitment of study participants in the United States was achieved by means of a school 
mailing, which included a letter describing the IBBS research study and a measure assessing 
ADHD symptomatology (Swanson, Nolan, and Pelham Rating Scale [SNAP]; Swanson, 
1992). If the parent/guardian completed and returned the rating scale, the SNAP was also 
completed by the child’s teacher. A child was considered “screen-positive” and invited to 
participate in a baseline assessment if the average rating per item was greater than 1.2 on the 
parent or teacher SNAP (Bussing et al., 2008). At baseline, child participants were evaluated 
using the Kiddie Schedule for Affective Disorders and Schizophrenia–Present and Lifetime 
Version (K-SADS-PL), which was administered by doctorate- or master-level clinicians as 
an interview with the child’s parent/guardian. Following a review of all available 
information (i.e., results of K-SADS-PL, prior psychological/medical history, scores on 
parent and teacher SNAPs), best estimate DSM-IV-TR diagnoses were assigned after 
consensus agreement was achieved by the research team. Neurocognitive tests were 
administered to participants by trained research assistants. Intellectual functioning was 
assessed by means of the Kaufman Brief Intelligence Test (K-BIT; Kaufman & Kaufman, 
2004). During baseline evaluations, parent and teacher rating scales were also completed.
Once participant eligibility was confirmed, children with ADHD or at subthreshold for 
ADHD were randomly assigned to either IBBS or TAU (IBBS = 48; TAU = 44). A method 
of randomly permuted blocks (block size = 4) stratified for treatment site (i.e., United States 
vs. China) and medication status (see Figure 1 for CONSORT diagram) was employed. The 
allocation scheme and random assignment of study participants was carried out using an 
online randomization generator (www.randomization.com) by the study biostatistician who 
was not involved in data collection. The IBBS treatment condition consisted of a total of 60 
sessions delivered in an after-school program format 4 days per week, 2 hours a day for 15 
weeks. After the first year of IBBS implementation, it was decided to reduce the program to 
3 days a week to allow for a planning day for program teachers and to offer child 
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participants time to engage in other extracurricular activities besides IBBS (a concern voiced 
by parents after soliciting feedback regarding their children’s participation in the first year of 
implementation). Therefore, participants in the second cohort received 45 sessions of IBBS 
treatment. The TAU condition lasted for the same duration (i.e., 15 weeks) as the IBBS 
treatment condition.
Endpoint assessments and rating scales were completed within 1 month of the last day of the 
program. This window of time was necessary to offer families a reasonable amount of 
options to schedule appointments with the assessment team outside of school hours. 
Clinicians and teachers evaluating ADHD symptomatology over time were blind to 
treatment assignment. To ensure blinding was maintained on behalf of study clinicians who 
assessed symptomatology post-treatment, research assistants reminded families to not 
mention their children’s treatment assignment to study clinicians immediately before 
meeting with them for endpoint evaluations. Children in the TAU group were offered the 
IBBS intervention following endpoint assessments.
The procedures followed by the assessment and implementation team in China were almost 
identical to the procedures outlined above with a few exceptions. These differences were 
driven by the need to be sensitive to cultural differences. Considering psychiatric disorders 
are not publicly discussed and parents do not inform teachers or school personnel of their 
children’s mental health diagnoses in China, recruitment through the school system was not 
an option. Instead, parents were informed about the study by means of delivering brochures, 
paid advertising, and announcements on social media. Moreover, in an effort to respect the 
privacy of parents, the IBBS program was not conducted in the same schools to which 
children were enrolled. As a result, the intervention took place at an off-site facility outside 
of school hours 3 times a week, 90 minutes a day, for 15 weeks. The blinded evaluations 
were completed by an assessment team comprised of psychiatric doctors and researchers in 
the areas of pediatrics and psychology.
Behavioral Outcomes
ADHD symptoms were assessed using the SNAP. The SNAP has been used repeatedly in the 
extant literature as a primary outcome measure (e.g., MTA Cooperative Group, 1999a, 
1999b; Swanson et al., 2011). It is composed of 26 items where 18 items assess ADHD 
symptoms (nine inattentive, nine hyperactive/impulsive) and eight items assess oppositional 
defiant disorder (ODD) symptoms. Blinded clinicians, parents, and teachers were asked to 
rate symptoms on a 4-point scale (0 = not at all, 1 = just a little, 2 = quite a bit, 3 = very 
much) at baseline and endpoint. A total score was calculated by summing all 18 items 
specific to ADHD. For the purposes of this study, the clinician total score on the SNAP was 
treated as a primary outcome measure. Cronbach’s alphas ranged from .86 to .94 for the 
inattentive subscale and from .84 to .94 on the hyperactive/impulsive subscale across all 
three raters (i.e., blinded clinicians, parents, teachers).
The Clinical Global Impression–Improvement (CGI-I) scale also served as a primary 
outcome measure to assess improvement in ADHD symptom severity following treatment 
(Guy, 1976). The CGI-I is a single item scale where improvement was rated on a 7-point 
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scale by blinded clinicians. Responders to treatment were defined as improved, much 
improved, or very much improved.
Neurocognitive Outcomes
A neurocognitive assessment battery lasting approximately 45 minutes was administered at 
baseline and endpoint by highly trained research assistants supervised by a licensed clinical 
psychologist. This battery included the children’s version of the California Verbal Learning 
Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987) to measure verbal learning and memory, 
the Wide Range Assessment of Memory and Learning–Second Edition (WRAML-2) Finger 
Windows forward (Adams & Sheslow, 1990) and backward (Bedard, Jain, Johnson, & 
Tannock, 2007) to assess spatial working memory and spatial storage manipulation, and the 
Flanker Task (Eriksen & Eriksen, 1974) to assess sustained attention and response 
inhibition. It is important to note that the assessment battery used by the research team in 
China did not include the Flanker as they did not have access to the computer program 
supporting this paradigm (i.e., E-Prime). In addition, children from the U.S. sample who 
received a Flanker accuracy score of less than .70 on congruent trials were excluded from 
analyses for the Flanker outcome variables only because these participants were thought to 
be disengaged from the task or not following test instructions, thus invalidating their 
performance. See Supplementary Appendix S2 for a description of each neurocognitive 
measure and what variables were identified a priori as capturing treatment effects.
Statistical Analyses
Baseline characteristics between the IBBS intervention and TAU groups as well as 
differences between sites (i.e., China vs. United States) were compared using t tests or 
ANOVAs for continuous variables and chi-square tests for categorical variables. ANCOVAs 
were used to test the difference between groups following treatment for all primary and 
secondary outcome measures using SAS Version 9.3. For each outcome, the model included 
the endpoint measurement as the dependent variable, group (i.e., IBBS vs. TAU) as the 
independent variable, and baseline score, age, medication status, ADHD subtype, and 
treatment site (i.e., China vs. U.S. sites) as covariates. Non-parametric tests were used for 
those outcome measures that did not meet parametric assumptions (e.g., variable was not 
normally distributed). Clinical Global Improvement scores were evaluated using chi-square 
tests. Missing data were imputed using the last observation carried forward (LOCF) or 
intent-to-treat approach as well as multiple imputation (MI) as both methods have been used 
extensively in treatment outcome studies to handle missing data (e.g., Chacko et al., 2014; 
van Dongen-Boomsma et al., 2014). As there were no differences in results when imputing 
(using LOCF or MI) or not imputing missing values, the results of study analyses are 
presented using the raw data of all study completers (i.e., those participants who were 
randomized and completed end-point assessments). To control for multiple comparisons, the 
linear step-up (LSU) procedure was adopted (Maxwell & Delaney, 2004). Following this 
procedure, the p value obtained from all analyses testing the main study hypotheses, starting 
with the smallest value, is compared with the equation (i/m) α, where i is assigned a value of 
1 and increases by 1 until reaching m, m is the total number of comparisons, and α is equal 
to .05. If the observed p values from these analyses are less than the corrected alpha level, 
the findings are deemed significant. For ease of interpretation, the corrected p values will be 
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presented when reporting significant findings. Finally, Cohen’s d (i.e., the difference 
between the change scores of each group divided by the pooled standard deviations at 
baseline) was calculated as a measure of effect size.
Results
Demographic Characteristics
No significant differences between groups (IBBS vs. TAU) were detected at baseline with 
respect to demographic or clinical characteristics (see Table 1). However, significant 
differences were found between the U.S. and China participants on the baseline clinician 
SNAP, t(90) = 2.83, p = .006; parent SNAP, t(90) = 2.49, p = .014; and teacher SNAP scores, 
t(90) = 2.84, p < .001, when not subdivided according to treatment assignment. In all 
instances, the participants from China had higher mean scores than the U.S. participants 
(clinician SNAP: U.S. M = 28.8, SD = 6.9; China M = 34.1, SD = 9.2; parent SNAP: U.S. M 
= 27.7, SD = 11.2; China M = 34.5, SD = 9.3; teacher SNAP: U.S. M = 23.0, SD = 12.8; 
China M = 34.5, SD = 7.9). As expected from previous research, clinician, parent, and 
teacher SNAP scores were all significantly correlated (rs ranging from .29 to .73) with the 
most modest correlation found between parent and teacher SNAPs, r = .29, p = .005 (see 
Narad et al., 2015).
Treatment Compliance
On average, children played the IBBS computer games for 18.1 hours (SD = 4.3) across the 
15-week IBBS treatment period with a target playing time of 20 hours. Previous studies have 
defined treatment compliance as completing 80% of the total number of training periods 
(e.g., Chacko et al., 2014; Klingberg et al., 2005; van Dongen-Boomsma et al., 2014). 
Therefore, we defined treatment compliance as completing 80% of the target playing time 
(i.e., 16 hrs). With this criterion in place, 25 out of 32 children were identified as treatment 
compliers in the IBBS group. In the following paragraphs, the results for the treatment 
compliers and all study completers (i.e., children who were randomized and completed 
endpoint evaluations) are presented.
Behavioral and Neurocognitive Outcomes for Study Completers
All results of group-wise treatment differences for the behavioral and neurocognitive 
outcome measures for study completers are presented in Table 2. There were no treatments 
effects found for clinician, teacher, or parent SNAP scores. Although there were no 
significant treatment group differences on the CGI-I scale, 25 out of 42 participants (60%) 
were classified as responders in the IBBS group and 21 out of 38 participants (55%) were 
classified as responders in the TAU group, as determined by scores on the CGI-I outcome 
measure.
A significant treatment group difference in favor of IBBS was found on CVLT total learning 
(p = .05); however, this finding did not survive the LSU corrected significant level of .004. 
No other treatment effects were found on any of the remaining neurocognitive outcome 
measures. The covariates of interest (i.e., age, medication status, ADHD subtype, treatment 
site) had no significant effect on study outcomes. Finally, it should be noted that the results 
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for treatment compliers versus all study completers on the treatment outcome measures did 
not dramatically differ with the exception of the CVLT total learning score. For treatment 
compliers, the treatment group difference in favor of IBBS only approached significance, 
F(1, 60) = 2.96, p = .09.
Discussion
The purpose of this study was to evaluate the efficacy of a new non-pharmacological 
intervention for young children with ADHD. A multi-site, randomized, wait-list controlled 
design was used to evaluate the effects of the IBBS intervention on outcome measures of 
ADHD symptomatology, global clinical functioning, and neurocognitive abilities. The 
results of this study revealed no statistically significant treatment effects on any of the 
primary outcome measures. In terms of secondary outcome measures, the IBBS group 
showed significant improvement on a verbal working memory task; however, this result did 
not survive correction for multiple group comparisons.
Given the integrative nature of IBBS (i.e., comprised of multiple modalities of training) and 
the enhancements made to the brain component of this intervention (i.e., difficulty of 
training matches performance level, online corrective messaging), it was predicted that IBBS 
would not only improve trained cognitive domains, but also generalize to symptoms of 
ADHD and global clinical functioning. However, the results of this study were not 
supportive of these hypotheses. Instead, these results were consistent with previous studies 
and meta-analytic reviews of CCRTs where moderate near-transfer effects (i.e., effects on 
trained tasks) are consistently found for working memory, but evidence of far-transfer effects 
(i.e., effects on untrained tasks) on blinded ratings of ADHD symptoms and untrained 
neurocognitive measures are lacking (Chacko et al., 2014; Rapport et al., 2013; Sonuga-
Barke et al., 2013; van Dongen-Boomsma et al., 2014).
The lack of significant treatment effects, especially when IBBS is comprised of intervention 
components that have shown promise in improving ADHD symptoms and untrained 
cognitive abilities, is worthy of attention. First, the cognitive processes trained by the brain 
component of IBBS may not be engaging the right neural pathway to result in improvements 
at the symptom level considering other circuitry deficits have been implicated in ADHD (see 
Bush, 2010, for a review) or perhaps engagement without real-world application is not 
enough. It is also possible that the time spent playing video games or using the computer 
outside of IBBS sessions may have differentiated groups (IBBS vs. TAU), as this was not 
monitored or controlled for during the study. Second, the body component of IBBS may not 
have produced the expected treatment effects because the physical activities shown to 
improve cognitive functioning and parent/teacher ratings of ADHD in previous studies 
required whole body movements and great amounts of energy expended with less of a focus 
on specific skill acquisition (e.g., Chang et al., 2012; Verret et al., 2012). This highlights a 
limitation of our study, as we did not capture the energy exerted by study participants during 
the body component of treatment or control for physical exercise acquired outside of the 
IBBS program. Third, the GBG was used as a tool by the implementation team to limit 
disruptions and to promote engagement in the IBBS treatment protocol, but was not intended 
to be an active component of treatment. However, the GBG is considered an evidence-based 
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prevention strategy in its own right based on its long-term impact on impulsive, disruptive, 
and antisocial behaviors (see Embry, 2002). It should be noted that in studies finding 
treatment effects, the GBG is played throughout the school day for an entire academic year 
and with classmates who serve as strong social reinforcers because of their large and 
influential role in children’s social networks. Fourth, the IBBS treatment dosage and timing 
(i.e., after-school setting) may not have been optimal. Initially, children were expected to 
participate in the IBBS after-school program 4 days a week for a period of 15 weeks. 
However, the number of days per week were reduced for the second cohort after receiving 
feedback from parents and teachers that children often returned home exhausted, were 
resistant to completing important school-related responsibilities (i.e., homework), and it 
made their participation in other after-school activities impossible. Thus, longer treatment 
periods especially in an after-school format may not have been feasible or well-tolerated. 
Fifth, it is possible that other neuropsychological measures (e.g., Continuous Performance 
Task) may have been sensitive to treatment change. Finally, the heterogeneity of our sample 
(i.e., subthreshold ADHD presentation, inclusion of most comorbidities) may have limited 
our ability to detect significant group differences following treatment.
In sum, the results of this study did not find evidence for the benefits of IBBS over TAU 
based on our primary outcome measures. This suggests that expanding cognitive training to 
multiple domains by means of two training modalities (i.e., computerized and physical 
exercises) does not lead to generalized improvement of ADHD symptomatology. Giving 
these findings and the recently published data of other treatment outcome studies for 
CCRTs, it appears that CCRTs without real-world application should not be recommended 
as a treatment for young children with ADHD. However, the possibility that cognitive 
training and physical exercise may help reduce symptoms of ADHD should not be ruled out 
completely. Although research on physical exercise and its impact on ADHD is still in its 
infancy stages, there is some evidence to suggest that moderate-to-vigorous exercise does 
translate into ADHD symptom reduction (Smith et al., 2013; Verret et al., 2012). However, 
more work is needed to determine the type and dose of physical activity that is required to 
produce these positive outcomes. With regard to cognitive training, future studies should 
consider establishing individual neurocognitive profiles of children and then tailoring the 
cognitive training to meet their needs in real-world situations or settings. Such an approach 
may better reflect the potential of cognitive training if ADHD symptoms or level of 
impairment are shown to be beneficially affected following such a treatment approach.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
CONSORT 2010 flow diagram.
aTwo participants returned for follow-up visit and were included in the analysis.
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Table 1
Demographic and Clinical Characteristics of IBBS and TAU Groups for Study Completers.
IBBS intervention
M (SD)
n = 42
Treatment-As-Usual
M (SD)
n = 38
Group differences
Test statistic
Age (years) 7.6 (0.9) 7.2 (1.2) t(78) = 1.55, p = .12
Sex, n (%)
  Male 30 (71) 23 (61) χ2(1) = 1.1, p = .3
  Female 12 (29) 15 (39)
Race, n (%)
  White 18 (43) 14 (37)
  African American 3 (7) 3 (8)
  Hispanic 4 (10) 7 (18) χ2(4) = 1.6, p = .8
  Asian 11 (26) 8 (21)
  Other 6 (14) 6 (16)
ADHD subtype, n (%)
  Inattentive 12 (28) 8 (21) χ2(1) = 0.6, p = .4
  Hyperactive-impulsive 7 (17) 5 (13) χ2(1) = 0.2, p = .7
  Combined 15 (36) 16 (42) χ2(1) = 0.3, p = .6
  Subthreshold for ADHD 8 (19) 9 (24) χ2(1) = 0.3, p = .6
Clinician SNAP 29.8 (8.2) 28.8 (6.8) t(78) = 0.59, p = .56
Parent SNAP 29.1 (12.2) 27.8 (9.7) t(77) = 0.53, p = .60
Teacher SNAPa 23.4 (12.0) 22.5 (12.5) t(63) = 0.27, p = .79
CGI-S 3.8 (0.9) 3.8 (0.7) t(60) = 0.10, p = .92
Full IQ 109.0 (15.2) 104.9 (15.7) t(78) = 1.18, p = .24
Medications, n (%)
  ADHD medication 7 (17) 6 (16) χ2(1) = 0.01, p = 1
    Stimulants 5 (12) 6 (16) χ2(1) = 0.3, p = .6
    Non-stimulants 3 (7) 1 (3) p = .62b
  SSRIs 1 (2) — p = 1.0b
Parental education (years) 15.4 (2.5) 15.6 (2.5) t(76) = 0.45, p = .66
Comorbidity, n (%)
  Tic disorder 1 (2) — p = 1.0b
  Depression 1 (2) 1 (3) p = 1.0b
  Anxiety disorder 7 (17) 8 (21) χ2(1) = 0.2, p = .7
  Enuresis 4 (10) 3 (8) p = 1.0b
  Oppositional defiant disorder 6 (14) 4 (11) p = .73b
  Autism spectrum disorder — 3 (8) p = .11b
  Speech problems 1 (2) 2 (5) p = .61b
Note. IBBS = Integrated Brain, Body, and Social intervention; TAU = treatment-as-usual; n = number of participants; SNAP = Swanson, Nolan, 
and Pelham Rating Scale; CGI-S = Clinical Global Impression–Severity scale; SSRIs = selective serotonin reuptake inhibitors.
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a
Data available for U.S. sample only.
b
Fisher’s exact test.
J Atten Disord. Author manuscript; available in PMC 2017 November 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Smith et al. Page 25
Ta
bl
e 
2
Te
st
 o
f G
ro
up
-W
ise
 (I
BB
S v
s. 
TA
U
) T
re
at
m
en
t D
iff
er
en
ce
s.
IB
BS
 n
IB
BS
-b
as
el
in
e
M
 
(S
D
)
IB
BS
-
en
dp
oi
nt
M
 
(S
D
)
TA
U
 n
TA
U
-b
as
el
in
e
M
 
(S
D
)
TA
U
-
en
dp
oi
nt
M
 
(S
D
)
Te
st
 st
at
ist
ic
Ef
fe
ct
 si
ze
p 
v
a
lu
e
Cl
in
ic
ia
n 
SN
A
P
42
29
.8
 (8
.2)
26
.8
 (8
.6)
38
28
.8
 (6
.8)
25
.6
 (7
.1)
F(
1, 
72
) =
 0.
05
−
0.
02
.
8
Pa
re
n
t S
NA
P
41
29
.1
 (1
2.2
)
23
.4
 (9
.8)
38
27
.8
 (9
.7)
24
.4
 (7
.8)
F(
1, 
71
) =
 0.
54
0.
21
.
5
Te
ac
he
r S
NA
Pa
34
23
.4
 (1
2.0
)
25
.1
 (1
0.5
)
31
22
.5
 (1
2.5
)
25
.2
 (1
2.0
)
F(
1, 
58
) =
 .1
3
0.
08
.
7
Fi
ng
er
 W
in
do
w
Fo
rw
ar
ds
a
30
11
.2
 (2
.8)
12
.3
 (3
.2)
25
10
.0
 (2
.2)
11
.8
 (3
.1)
F(
1, 
47
) =
 .0
0
−
0.
29
1.
0
Fi
ng
er
 W
in
do
w
B
ac
kw
ar
da
29
9.
4 
(3.
7)
10
.5
 (3
.0)
24
8.
2 
(3.
3)
10
.4
 (3
.6)
F(
1, 
45
) =
 1.
83
−
0.
32
.
2
CV
LT
 
 
To
ta
l l
ea
rn
in
g
41
33
.8
 (1
0.0
)
41
.0
 (9
.7)
37
32
.4
 (1
2.0
)
36
.7
 (1
2.4
)
F(
1, 
69
) =
 4.
00
0.
27
.
04
9
 
 
Sh
or
t d
el
ay
re
ca
ll
41
6.
3 
(2.
9)
8.
1 
(2.
7)
37
6.
1 
(3.
4)
7.
2 
(2.
7)
F(
1, 
69
) =
 1.
92
0.
19
.
2
 
 
Lo
ng
 d
el
ay
re
ca
ll
41
6.
7 
(3.
2)
8.
3 
(2.
8)
37
6.
3 
(4.
0)
7.
2 
(3.
6)
F(
1, 
69
) =
 2.
00
0.
19
.
2
Fl
an
ke
ra
 
 
RT in
te
rfe
re
nc
e
sc
o
re
29
15
2 
(10
6)
12
5 
(12
9)
25
18
5 
(17
8)
16
0 
(10
8)
F(
1, 
46
) =
 .2
2
0.
02
.
6
 
 
Er
ro
r
in
te
rfe
re
nc
e
sc
o
re
29
9.
3 
(12
.1)
5.
8 
(6.
58
)
25
16
.3
 (2
1.1
3)
4.
96
 (4
.75
)
Z 
=
 .
93
−
0.
46
.
4
 
 
RT
 v
ar
ia
bi
lit
y
in
co
ng
ru
en
t
29
36
4 
(16
7)
31
1 
(18
2)
25
40
5 
(14
8)
31
2 
(11
5)
F(
1, 
46
) =
 0.
03
−
0.
25
.
9
 
 
RT
CV
in
co
ng
ru
en
t
29
0.
36
 (0
.15
)
0.
34
 (0
.13
)
25
0.
37
 (0
.15
)
0.
30
 (0
.08
)
F(
1, 
46
) =
 .8
6
−
0.
33
.
4
CG
I-I
, n
 
(%
)
—
25
 (6
0)
—
21
 (5
5)
χ2
(1)
 = 
0.1
5
—
.
7
N
ot
e. 
IB
B
S 
= 
In
te
gr
at
ed
 B
ra
in
, B
od
y, 
an
d 
So
ci
al
 in
te
rv
en
tio
n;
 T
AU
 =
 tr
ea
tm
en
t-a
s-
us
ua
l; 
n
 
=
 n
u
m
be
r o
f p
ar
tic
ip
an
ts;
 S
NA
P 
= 
Sw
an
so
n
, 
N
ol
an
, a
nd
 P
el
ha
m
 R
at
in
g 
Sc
al
e;
 C
V
LT
 =
 C
al
ifo
rn
ia
 V
er
ba
l 
Le
ar
ni
ng
 T
es
t; 
RT
 =
 re
ac
tio
n 
tim
e;
 E
rro
r =
 d
ire
ct
io
na
l e
rro
rs
; R
TC
V
 =
 re
ac
tio
n 
tim
e 
co
ef
fic
ie
nt
 o
f v
ar
ia
tio
n;
 C
G
I-I
 =
 C
lin
ic
al
 G
lo
ba
l I
m
pr
es
sio
n–
Im
pr
ov
em
en
t.
a D
at
a 
av
ai
la
bl
e 
fo
r U
.S
. S
am
pl
e 
on
ly
.
J Atten Disord. Author manuscript; available in PMC 2017 November 13.
